Compass Pathways

Compass PathwaysCompass Pathways
CP

Compass Pathways

Accelerating patient access to evidence-based innovation in mental health.

DR 662018Active241London, United Kingdom
Rate

About

Compass Pathways is a mental health company dedicated to accelerating patient access to evidence-based innovation in mental health. They are developing COMP360, a psilocybin therapy, and are focused on training healthcare providers to deliver this investigational treatment.
Frequently asked

What does Compass Pathways do?

Compass Pathways is a mental health company dedicated to accelerating patient access to evidence-based innovation in mental health. They are developing COMP360, a psilocybin therapy, and are focused on training healthcare providers to deliver this investigational treatment.

What is Compass Pathways's revenue?

StartupHub estimates Compass Pathways's annual revenue at $33.9M (range $18.9M to $87.9M, 68% confidence), based on comparable companies in the sector.

What is Compass Pathways's valuation?

StartupHub estimates Compass Pathways's effective valuation at $561.0M (range $392.7M to $729.3M, 28% confidence), based on comparable companies in the sector.

How much funding has Compass Pathways raised?

Compass Pathways has raised a total of $294M in funding. The most recent round on record is IPO.

Where is Compass Pathways headquartered?

Compass Pathways is headquartered in London, England, United Kingdom.

When was Compass Pathways founded?

Compass Pathways was founded in 2018.

What industry does Compass Pathways operate in?

Compass Pathways operates in Biotechnology, Healthcare, Mental Health, Pharmaceuticals.

How many employees does Compass Pathways have?

Compass Pathways has approximately 241 people on record.

HEADCOUNT
241
DOMAIN RATING
66
Comments

No comments yet. Be the first to share your take.